I Arm-Wrestled NFL Rookie Dee Ford to Teach Athletes About Money
Nothing Doing: Market Closes Virtually Unchanged After Mixed News
Merck & Co., Inc.
View this photo on glassdoor.com
Cramer's Mad Money - 2 Picks From Leon Cooperman (7/24/14)
Merck Looks Overpriced Compared To This Sector Peer
Daily Dividend Report: INTC, MRK, V, BLK, AAL
Gilead Sciences Q2 2014: All Is Good, More To Come At Medical Conferences Later This Year
Merck & Co. Inc.: I'm Long, But It Screams Overvalued Today
Is Inovio Undervalued After Positive HPV Therapy Results?
Roche Earnings Preview: Continued Adoption For Key Cancer Drugs Will Drive Growth
3 Stocks Reiterated As A Buy: MDLZ, MRK, IBM
Bad Times Continue To Hit Merck's Animal Health Segment
Johnson & Johnson Earnings: New Blockbuster Drug Olysio Lifts Sales But May Face Competition Soon